These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 1753342

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. HIV infection and AIDS risk behaviors among injecting drug users entering methadone treatment: an update.
    Battjes RJ, Pickens RW, Brown LS.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep 01; 10(1):90-6. PubMed ID: 7648291
    [Abstract] [Full Text] [Related]

  • 3. HIV risk factors among injecting drug users in five US cities.
    Battjes RJ, Pickens RW, Haverkos HW, Sloboda Z.
    AIDS; 1994 May 01; 8(5):681-7. PubMed ID: 8060548
    [Abstract] [Full Text] [Related]

  • 4. HIV infection among intravenous drug users: epidemiology and risk reduction.
    Des Jarlais DC, Friedman SR.
    AIDS; 1987 Jul 01; 1(2):67-76. PubMed ID: 3130084
    [Abstract] [Full Text] [Related]

  • 5. Seroprevalence of human T cell lymphotropic virus type II infection, with or without human immunodeficiency virus type 1 coinfection, among US intravenous drug users.
    Briggs NC, Battjes RJ, Cantor KP, Blattner WA, Yellin FM, Wilson S, Ritz AL, Weiss SH, Goedert JJ.
    J Infect Dis; 1995 Jul 01; 172(1):51-8. PubMed ID: 7797946
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Behavioral characteristics of seroconverted intravenous drug users.
    Nemoto T.
    Int J Addict; 1992 Dec 01; 27(12):1413-21. PubMed ID: 1452392
    [Abstract] [Full Text] [Related]

  • 8. Risk behaviors, HIV seropositivity, and tuberculosis infection in injecting drug users who operate shooting galleries in Puerto Rico.
    Robles RR, Marrero CA, Reyes JC, Colón HM, Matos TD, Finlinson HA, Muñoz A, Meléndez M, Sahai H.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr 15; 17(5):477-83. PubMed ID: 9580534
    [Abstract] [Full Text] [Related]

  • 9. Age at first injection and HIV risk among intravenous drug users.
    Battjes RJ, Leukefeld CG, Pickens RW.
    Am J Drug Alcohol Abuse; 1992 Apr 15; 18(3):263-73. PubMed ID: 1415084
    [Abstract] [Full Text] [Related]

  • 10. Long-term trends in self-reported HIV risk behavior: injection drug users in Los Angeles, 1987 through 1995.
    Longshore D, Annon J, Anglin MD.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 May 01; 18(1):64-72. PubMed ID: 9593460
    [Abstract] [Full Text] [Related]

  • 11. "Why I am not infected with HIV": implications for long-term HIV risk reduction and HIV vaccine trials.
    Des Jarlais DC, Vanichseni S, Marmor M, Buavirat A, Titus S, Raktham S, Friedmann P, Kitayaporn D, Wolfe H, Friedman SR, Mastro TD.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Dec 15; 16(5):393-9. PubMed ID: 9420319
    [Abstract] [Full Text] [Related]

  • 12. Population-based study of malignancies and HIV infection among injecting drug users in a New York City methadone treatment program, 1985-1991.
    Gachupin-Garcia A, Selwyn PA, Budner NS.
    AIDS; 1992 Aug 15; 6(8):843-8. PubMed ID: 1329849
    [Abstract] [Full Text] [Related]

  • 13. Psychological dysfunction and HIV/AIDS risk behavior.
    Camacho LM, Brown BS, Simpson DD.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Feb 01; 11(2):198-202. PubMed ID: 8556403
    [Abstract] [Full Text] [Related]

  • 14. Risk factors for HIV seropositivity in a sample of drug users in drug treatment in Ho Chi Minh City, Vietnam.
    Tran SD, Williams AB, Truong HT, Do NH.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar 01; 17(3):283-7. PubMed ID: 9495230
    [Abstract] [Full Text] [Related]

  • 15. Condom use with primary partners among injecting drug users in Bangkok, Thailand and New York City, United States.
    Vanichseni S, Des Jarlais DC, Choopanya K, Friedmann P, Wenston J, Sonchai W, Sotheran JL, Raktham S, Carballo M, Friedman SR.
    AIDS; 1993 Jun 01; 7(6):887-91. PubMed ID: 8363764
    [Abstract] [Full Text] [Related]

  • 16. Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study.
    Liu Y, Liu Y, Zou X, Chen W, Ling L.
    BMJ Open; 2017 Jul 13; 7(7):e015524. PubMed ID: 28710214
    [Abstract] [Full Text] [Related]

  • 17. Prospective effects of perceived risk of developing HIV/AIDS on risk behaviors among injection drug users in Puerto Rico.
    Robles RR, Cancel LI, Colón HM, Matos TD, Freeman DH, Sahai H.
    Addiction; 1995 Aug 13; 90(8):1105-11. PubMed ID: 7549779
    [Abstract] [Full Text] [Related]

  • 18. Incidence of HIV among injection drug users entering drug treatment programs in four US cities.
    Murrill CS, Prevots DR, Miller MS, Linley LA, Royalty JE, Gwinn M, Seroincidence Study Group.
    J Urban Health; 2001 Mar 13; 78(1):152-61. PubMed ID: 11368194
    [Abstract] [Full Text] [Related]

  • 19. HIV-related risk behaviors among cocaine users.
    Khalsa HK, Kowalewski MR, Anglin MD, Wang J.
    AIDS Educ Prev; 1992 Mar 13; 4(1):71-83. PubMed ID: 1311941
    [Abstract] [Full Text] [Related]

  • 20. Effectiveness of methadone treatment in reducing HIV risk behavior and HIV seroconversion among injecting drug users.
    Gibson DR, Flynn NM, McCarthy JJ.
    AIDS; 1999 Oct 01; 13(14):1807-18. PubMed ID: 10513638
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.